Mannkind Corporation (MNKD)
PHARMACEUTICAL PREPARATIONS
Mannkind Corporation (MNKD) is listed on Nasdaq, where it has traded since July 28, 2004.
- Listed On
- Nasdaq
- Listed Since
- July 28, 2004
- Employees
- 592
- Market Cap
- $1.1B
About Mannkind Corporation
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 249 institutions reported holding MNKD, with 181.6 million shares worth $772.9 million in aggregate. The largest reported holder was BlackRock, with 32.1 million shares worth $136.9 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| BlackRock | 32,133,223 | $137M | Added 12.35% |
| Vanguard | 18,765,461 | $80M | Added 0.96% |
| Rubric Capital Management | 18,000,000 | $77M | Added 397.18% |
| State Street | 16,174,043 | $69M | Reduced 13.43% |
| Geode Capital Management | 7,947,203 | $34M | Added 5.89% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is MNKD?
Mannkind Corporation (MNKD) is listed on Nasdaq, where it has traded since July 28, 2004.
Who are the largest institutional holders of MNKD?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of MNKD were BlackRock, Vanguard and Rubric Capital Management.
How many institutions own MNKD?
249 institutions reported a position in MNKD for the quarter ended June 30, 2026, worth $772.9 million in total.
Did institutions buy or sell MNKD last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for MNKD.
Every reported institutional holder, plus insider and congressional trades in MNKD, on SentiSense.